Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City
- PMID: 33429474
- PMCID: PMC7801150
- DOI: 10.3346/jkms.2021.36.e15
Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City
Abstract
Background: Data regarding the association between preexisting cardiovascular risk factors (CVRFs) and cardiovascular diseases (CVDs) and the outcomes of patients requiring hospitalization for coronavirus disease 2019 (COVID-19) are limited. Therefore, the aim of this study was to investigate the impact of preexisting CVRFs or CVDs on the outcomes of patients with COVID-19 hospitalized in a Korean healthcare system.
Methods: Patients with COVID-19 admitted to 10 hospitals in Daegu Metropolitan City, Korea, were examined. All sequentially hospitalized patients between February 15, 2020, and April 24, 2020, were enrolled in this study. All patients were confirmed to have COVID-19 based on the positive results on the polymerase chain reaction testing of nasopharyngeal samples. Clinical outcomes during hospitalization, such as requiring intensive care and invasive mechanical ventilation (MV) and death, were evaluated. Moreover, data on baseline comorbidities such as a history of diabetes, hypertension, dyslipidemia, current smoking, heart failure, coronary artery disease, cerebrovascular accidents, and other chronic cardiac diseases were obtained.
Results: Of all the patients enrolled, 954 (42.0%) had preexisting CVRFs or CVDs. Among the CVRFs, the most common were hypertension (28.8%) and diabetes mellitus (17.0%). The prevalence rates of preexisting CVRFs or CVDs increased with age (P < 0.001). The number of patients requiring intensive care (P < 0.001) and invasive MV (P < 0.001) increased with age. The in-hospital death rate increased with age (P < 0.001). Patients requiring intensive care (5.3% vs. 1.6%; P < 0.001) and invasive MV (4.3% vs. 1.7%; P < 0.001) were significantly greater in patients with preexisting CVRFs or CVDs. In-hospital mortality (12.9% vs. 3.1%; P < 0.001) was significantly higher in patients with preexisting CVRFs or CVDs. Among the CVRFs, diabetes mellitus and hypertension were associated with increased requirement of intensive care and invasive MV and in-hospital death. Among the known CVDs, coronary artery disease and congestive heart failure were associated with invasive MV and in-hospital death. In multivariate analysis, preexisting CVRFs or CVDs (odds ratio [OR], 1.79; 95% confidence interval [CI], 1.07-3.01; P = 0.027) were independent predictors of in-hospital death after adjusting for confounding variables. Among individual preexisting CVRF or CVD components, diabetes mellitus (OR, 2.43; 95% CI, 1.51-3.90; P < 0.001) and congestive heart failure (OR, 2.43; 95% CI, 1.06-5.87; P = 0.049) were independent predictors of in-hospital death.
Conclusion: Based on the findings of this study, the patients with confirmed COVID-19 with preexisting CVRFs or CVDs had worse clinical outcomes. Caution is required in dealing with these patients at triage.
Keywords: COVID-19; Cardiovascular Disease; Cardiovascular Risk Factors; Coronavirus; Prognosis; SARS-CoV-2.
© 2021 The Korean Academy of Medical Sciences.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures

Comment in
-
Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.J Korean Med Sci. 2021 Apr 19;36(15):e113. doi: 10.3346/jkms.2021.36.e113. J Korean Med Sci. 2021. PMID: 33876590 Free PMC article. No abstract available.
Similar articles
-
Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave.Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102148. doi: 10.1016/j.dsx.2021.05.021. Epub 2021 Jun 27. Diabetes Metab Syndr. 2021. PMID: 34186349 Free PMC article.
-
Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1017-1025. doi: 10.1016/j.dsx.2020.06.064. Epub 2020 Jul 2. Diabetes Metab Syndr. 2020. PMID: 32634716 Free PMC article.
-
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease.Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146. Iran J Allergy Asthma Immunol. 2021. PMID: 33904672
-
Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology.PLoS One. 2021 Aug 10;16(8):e0256023. doi: 10.1371/journal.pone.0256023. eCollection 2021. PLoS One. 2021. PMID: 34375366 Free PMC article.
-
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.BMC Cardiovasc Disord. 2021 Jan 7;21(1):23. doi: 10.1186/s12872-020-01816-3. BMC Cardiovasc Disord. 2021. PMID: 33413093 Free PMC article.
Cited by
-
National early warning score (NEWS) 2 predicts hospital mortality from COVID-19 patients.Ann Med Surg (Lond). 2022 Apr;76:103462. doi: 10.1016/j.amsu.2022.103462. Epub 2022 Mar 8. Ann Med Surg (Lond). 2022. PMID: 35284070 Free PMC article.
-
Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.J Korean Med Sci. 2021 Apr 19;36(15):e113. doi: 10.3346/jkms.2021.36.e113. J Korean Med Sci. 2021. PMID: 33876590 Free PMC article. No abstract available.
-
Correlation of Patient Profiles and Biomarkers with Outcomes in Covid-19 Icu Patients: A Retrospective Analysis.Rom J Anaesth Intensive Care. 2022 Dec 29;28(2):71-79. doi: 10.2478/rjaic-2021-0012. eCollection 2021 Dec. Rom J Anaesth Intensive Care. 2022. PMID: 36844114 Free PMC article.
-
Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study.Front Med (Lausanne). 2022 Dec 22;9:1045274. doi: 10.3389/fmed.2022.1045274. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36619633 Free PMC article.
-
Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis.PLoS One. 2023 Oct 10;18(10):e0292021. doi: 10.1371/journal.pone.0292021. eCollection 2023. PLoS One. 2023. PMID: 37815980 Free PMC article.
References
-
- World Health Organization. WHO Director- General's opening remarks at the media briefing on COVID-19 - 11 March 2020. [Updated 2020]. [Accessed March 12, 2020]. https://www.who.int/director-general/speeches/detail/who-director-genera....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous